Clinical/Research Interests

Ralph W. deVere White is associate dean for cancer programs at UC Davis School of Medicine, director of the UC Davis Cancer Center and a professor of urology. He received his medical degree from Dublin University in Dublin, Ireland, and completed an internship and residencies in surgery and urology at St. Vincent's Hospital in Dublin and at Duke University Medical Center in Durham, NC.

The author of more than 250 peer-reviewed scientific articles and book chapters, Dr. deVere White serves on the editorial boards of six international scientific journals. His current research efforts focus on investigating the genetic mistakes that give rise to prostate cancer, the biomolecular mechanisms that make some prostate cancers more virulent than others, and new methods of diagnosing and treating prostate cancer. He is the immediate past president-elect of the Society of Urologic Oncology, a member of the Clinical Society of Genitourinary Surgeons and an elected member of the prestigious American Association of Genitourinary Surgeons. He has been named multiple times as one of "The Best Doctors in America" and is one of four urologists serving as a volunteer consultant to the American Cancer Society's on-line "Experts Answers" bulletin board for questions about prostate cancer.

Specialty:

Center/Program Affiliation:

Address:

Phone:

Education:

Residency:

Board Certifications:

Professional Memberships:

Select Recent Publications:

Nicholas J. Hellenthal, M.D., Michelle L. Ramírez, D.O., Christopher P. Evans, M.D., Ralph W. deVere White, M.D., Theresa M. Koppie, M.D. Trends in Pelvic Lymphadenectomy at the Time of Radical Cystectomy 1988-2004. Journal of Urology, 2009 Jun;181(6):2490-5. Epub 2009 Apr 16.

Ralph W. de Vere White, Ruth L. Vinall, Clifford G. Tepper, Xu-Bao Shi, “MicroRNA's and their Potential for Translation in Prostate Cancer” Urologic Oncology: 27 (2009) 307-311.

Xu-Bao Shi, Lingru Xue, June X. Zou, Regina Gandour-Edwards, Hongwu Chen and Ralph W. de Vere White “Prolonged Androgen Receptor Loading Onto Chromatin and the Efficient Recruitment of p160 Coactivators Contribute to Androgen-Independent Growth of Prostate Cancer.” The Prostate 68: 1816-1826.

Bedolla, RG, Asuncion, A, Chamie, K, Siddiqui, S, Troyer, DA, Mehra, R, Siddiqui, J, Chinnaiyan, AM, deVereWhite, RW, and Ghosh, PM. Nuclear vs Cytoplasmic localization of Filamin A in Prostate Cancer: Immunohistochemical Correlation with Metastases. Clinical Cancer Research. 2009; 15(3)788-96.

Barkauskas DA, Joo An H, Kronewitter SR, Lorna de Leoz M, Chew HK, deVere White RW, Leiserowitz GS, Miyamoto S, Lebrilla CB and Rocke DM. "Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass sepctrometry data." Bioinformatics. 2009 25(2):251-257.

Ralph W. de Vere White, Primo N. Lara, Bryan Goldman, Cathy M. Tangen, David C. Smith, David P. Wood, Maha H. Hussain and David Crawford, “A Sequential Treatment Approach to Myoinvasive Urothelial Cancer: A Phase II Southwest Oncology Group Trial (S0219).” Journal of Urology, 181; 2476-2481 June 2009

Ralph W. de Vere White, Mark H. Katz, and Gary Steinberg, “ The Case for Neoadjuvant Chemotherapy and Cystectomy for Muscle Invasive Bladder Cancer.” Journal of Urology, 181, 1994-1997, May 2009

Hellenthal NJ, Chamie K, Ramirez ML, deVere White RW. Sociodemographic factors associated with nephrectomy in patients with metastatic renal cell carcinoma. Journal of Urology Mar;181(3):1013-8; discussion 1018-9. Epub 2009 Jan 16.

Lorna de Leoz M, An H-J, Kronewitter S, Kim J, Beechroft S, Vinall R, Miyamoto S, deVere White RW, Lam KS, Lebrilla C. “Glycomic approach for potential biomarkers on prostate cancer: Profiling of N-linked glycans in human sera and pRNS cell lines. Dis Markers. 2008; 25(4-5):243-58.

Shi XB, Tepper CG, deVere White RW. Cancerous miRNAs and their regulation. Cell Cycle. 2008, Jun 1:7(11):1529-38.